Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Switching to Tenofovir Versus Continuing Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response During Entecavir Therapy: STEEP Study (STEEP)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2014 by Korea University.
Recruitment status was  Recruiting
Gilead Sciences
Information provided by (Responsible Party):
Hyung Joon Yim, Korea University Identifier:
First received: October 17, 2012
Last updated: February 26, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)